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Each January, the editors of Diabetes
Care look back at the last year and for-
ward to the next. In January 2021 we
have much to be thankful and happy
about. The journal continues to publish
outstanding scientific reports together
with illuminating and provocative Com-
mentary, Perspective, and Review ar-
ticles. We are indebted to the authors
who submit their manuscripts, the re-
viewers who evaluate them, and the
editorial and production group that
manages the process. They make it
all possible. In 2020, Diabetes Care’s
impact factor increased once again,
from 15.27 to 16.02. Accumulating sci-
entific evidence presented by our jour-
nal and others continues to improve
understanding of the pathophysiology
of diabetes and add to the array of
treatments.
And yet . . . it’s been a hell of a year in
other ways. The coronavirus disease
2019 (COVID-19) pandemic started a
year ago and still has the world in its
grip. It has tested all of us and brought
many activities nearly to a halt. Countless
people have fallen ill, sadly many have
died, and the daily routines of most
families are disturbed. The lockdown
to prevent spread of the virus keeps
people at home, limits travel, harms
businesses, closes schools, and interferes
with diagnosis and treatment of other
ailments. Acute medical facilities have
been overwhelmed in some regions.
Fierce debates about controlling the
spread of COVID-19 and mitigating its
human and economic costs have ensued.
Yet, in this crisis we see much heroism.
Medical personnel and those who sup-
port them have carried on, often at
personal risk; devoted families are caring
for children and older relatives; and
researchers in academia and industry
are seeking vaccines and other interven-
tions at a record pace.
Despite these efforts, containment of
COVID-19 by physical distancing andwear-
ing face masks has varied widely between
countries, regions within countries, and
groups ineachregion.Peoplewithdiabetes
are among the groups affected more than
the general population. They appear more
likely to become infected (1), likely for
socioeconomic and environmental rea-
sons, and are more likely to progress to
severe illnessordie for reasons thatarestill
not well understood (2). Our community
has an understandable feeling of urgency
about the development of vaccines to
prevent infection and drugs that lessen
its consequences. We also have become
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acutely aware that the pandemic calls
for more than medical interventionsdit
demands a renewed emphasis on public
health measures.
Factors collectively termed the social
determinants of health (SDOH) modulate
the risks and severity of both infectious
diseases and diabetes. These influences
extend well beyond primary health care,
specialized care for specific conditions, and
hospital care for acute illness. The SDOH
affect everyoneandhave social, economic,
and environmental components. The Cen-
ters for Medicare &Medicaid Services has
focused on housing instability, food in-
security, transportation problems, utility
needs, and personal safety concerns in a
pilot program examining whether support
for screening and referral for SDOH will
improve health outcomes. In this issue of
Diabetes Care, an American Diabetes As-
sociation-sponsored scientific review by
Hill-Briggs et al. draws attention to
SDOH as they relate specifically to diabetes
(3). This statement describes in detail the
evidence linking the risk of developing
diabetes and its complications to ethnicity,
economic status, availability of healthful
food and living conditions, and access to
health care, education, and social support.
When these factors are unfavorable, the
likelihood of obesity increases, recognition
and care of gestational diabetesmellitus
can be inadequate, diagnosis of type 2
diabetes may be delayed, and access to
treatment impaired.
As with diabetes, there is evidence link-
ing COVID-19 to SDOH (4,5). The risk of
exposure to viral infection can be higher
whenpreventive education is lacking,work-
ers cannot remain at home due to the fear
of losing income or employment, or
businesses have little guidance regarding
risk management. Diagnosis may be de-
layed and therapy less effective when
access to health care is impaired, often by
lack of nearby facilities or adequate in-
surance. Among the greatest tragedies of
the last year is the hardship experienced
by the most vulnerable groupsdamong
them older people, ethnic minorities, and
refugee populationsdwho are especially
vulnerable to diabetes and its complications
as well as COVID-19. A Commentary in
this issue by Ogunwole and Golden (6)
calls further attention to links between
health disparities and the effects of racism
and social injustice on SDOH.
To overcome SDOH-related barriers to
health, national and regional programs
that involve community-wide planning,
effort, and resources will be needed. The
most advancedmedical care is ineffective
when a commitment to public health is
lacking. Strong evidence to this point is
available. For example, Stephen Kunitz, a
medical anthropologist, tested the hy-
pothesis that health in a community cor-
relates with what he called an Index of
Institutionalism (7). The index included
objective measures of social beliefs and
behaviors reflecting the propensity of
state populations in the U.S. to “use
both private and public organizations
and institutions to advance what they
perceive to be the common good.” Com-
paring support of community institutions
with age-adjusted death rates led to two
important conclusions (Fig. 1). Indepen-
dent of local support of institutions, Af-
rican Americans had higher mortality
rates. Beyond that, higher death rates
were associated with lower support of
institutions at the state level in all sub-
groups. This observation argues that every-
one’s health depends on local support of
governmental and nongovernmental insti-
tutions.Awholecommunitymustbelievein
public healthandsupport theorganizations
contributing to it. These include the na-
tional Centers for Disease Control and
Prevention, state public health agencies,
and voluntary health organizations like the
American Diabetes Association, among
many others. Everyone should be aware
of these organizations and can contribute,
volunteer, and vote to support them.
Returning to Diabetes Care, we expect
to receive and publish many more
manuscriptson this topic in2021.Control
of COVID-19 is an urgent concern for
people with diabetes. We need to learn
more about how to improve outcomes for
people with hyperglycemia at diagnosis of
COVID-19, even when there is no prior
history of diabetes. Does control of hyper-
glycemia make a difference? Which forms
of drug therapy are most helpful and
which might worsen outcomes? However,
conventional diagnosis and therapy are
no longer enough. Both COVID-19 and
diabetes are public health crises that
require evidence-based approaches,
including a focus on the SDOH to reduce
morbidity and mortality. We need ob-
jective information about how to do this.
This should include sound epidemiologic
studies, preventive programs, screening,
regulatory curtailment of risk-enhancing
practices, and social and economic support
of all disadvantaged and vulnerable pop-
ulations. The job of Diabetes Care is to
report the science to support clinical care,
guidelines (8), and public policy, so please
send us your best work. Public health also
matters!
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Figure 1—Age-adjusted death rates of African Americans (solid lines) and White Americans
(broken lines) regressed onto the Index of Institutionalism in the 48 contiguous U.S. states, 1999–
2005. Adaptedwith permission of CambridgeUniversity Press through PLSclear fromFigure 2–2 in
Kunitz (7), © Stephen J. Kunitz, 2015.
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